Literature DB >> 23794341

Protective effect of tryptophan against dextran sulfate sodium- induced experimental colitis.

Toru Shizuma1, Hidezo Mori, Naoto Fukuyama.   

Abstract

BACKGROUND/AIMS: Little is known about the anti-colitis effect of tryptophan or its metabolites. Here, the protective effect and its mechanism of tryptophan administration on dextran sulfate sodium -induced colitis in mice was studied.
MATERIALS AND METHODS: Twenty C57black6 female mice were equally divided into the control group, and treatment group. The control group received a standard CE-2 diet, while the tryptophan group received a CE-2 diet containing 0.5% l-tryptophan. After one week on this diet, all mice were orally administered a solution of 3.5% dextran sulfate sodium for 12 days to induce colitis. Changes in body weight and bloody stool frequency were monitored during dextran sulfate sodium administration. At 12 days post initial dextran sulfate sodium administration, all mice were sacrificed and the histology of their colonic tissue was examined. The nitrotyrosine levels in colonic tissues in both groups, and nitrate and nitrite levels in the urine of the control group, the tryptophan group and the group of mice without dextran sulfate sodium administration was measured.
RESULTS: The tryptophan group showed significantly attenuated body weight loss, bloody stool frequency and ameliorated histological changes of colitis. While tryptophan treatment significantly reduced nitrotyrosine level in the colonic tissues, there was no significant reduction in urine nitrate and nitrite levels compared with the (dextran sulfate sodium-induced) control group.
CONCLUSION: Tryptophan treatment ameliorated dextran sulfate sodium-induced colitis in this study. One of the anti-colitis mechanisms of tryptophan treatment is attributable to an anti-nitration effect, and may not be via the suppression of nitric oxide generation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794341     DOI: 10.4318/tjg.2013.0558

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  9 in total

1.  Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor.

Authors:  Samantha A Scott; Jingjing Fu; Pamela V Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

Review 2.  Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?

Authors:  Sandra Vidal-Lletjós; Martin Beaumont; Daniel Tomé; Robert Benamouzig; François Blachier; Annaïg Lan
Journal:  Nutrients       Date:  2017-03-21       Impact factor: 5.717

Review 3.  Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.

Authors:  Yulan Liu; Xiuying Wang; Chien-An Andy Hu
Journal:  Nutrients       Date:  2017-08-23       Impact factor: 5.717

Review 4.  Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review.

Authors:  Xueyan Ding; Peng Bin; Wenwen Wu; Yajie Chang; Guoqiang Zhu
Journal:  Mediators Inflamm       Date:  2020-06-12       Impact factor: 4.711

5.  Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis.

Authors:  Aleksandar Acovic; Bojana Simovic Markovic; Marina Gazdic; Aleksandar Arsenijevic; Nemanja Jovicic; Nevena Gajovic; Marina Jovanovic; Natasa Zdravkovic; Tatjana Kanjevac; C Randall Harrell; Crissy Fellabaum; Zana Dolicanin; Valentin Djonov; Nebojsa Arsenijevic; Miodrag L Lukic; Vladislav Volarevic
Journal:  Therap Adv Gastroenterol       Date:  2018-08-24       Impact factor: 4.409

6.  Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis.

Authors:  Vladislav Volarevic; Natasa Zdravkovic; Carl Randall Harrell; Nebojsa Arsenijevic; Crissy Fellabaum; Valentin Djonov; Miodrag L Lukic; Bojana Simovic Markovic
Journal:  Cells       Date:  2019-07-12       Impact factor: 6.600

7.  Plasma amino acid profiles in dogs with inflammatory bowel disease.

Authors:  Yu Tamura; Hiroshi Ohta; Yumiko Kagawa; Tatsuyuki Osuga; Keitaro Morishita; Noboru Sasaki; Mitsuyoshi Takiguchi
Journal:  J Vet Intern Med       Date:  2019-05-20       Impact factor: 3.333

Review 8.  Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.

Authors:  Li-Ming Chen; Chun-Hui Bao; Yu Wu; Shi-Hua Liang; Di Wang; Lu-Yi Wu; Yan Huang; Hui-Rong Liu; Huan-Gan Wu
Journal:  J Neuroinflammation       Date:  2021-06-14       Impact factor: 8.322

9.  Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.

Authors:  Harmit S Ranhotra; Kyle L Flannigan; Martina Brave; Subhajit Mukherjee; Dana J Lukin; Simon A Hirota; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.